Western Financial Corp/Ca Arrowhead Pharmaceuticals, Inc. Transaction History

Western Financial Corp/Ca

  • $230 Billion
  • Q3 2025

A detailed history of Western Financial Corp/Ca transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Western Financial Corp/Ca holds 820,239 shares of ARWR stock, worth $33.8 Million. This represents 12.31% of its overall portfolio holdings.

Number of Shares
820,239
Previous 820,239 -0.0%
Holding current value
$33.8 Million
Previous $13 Billion 118.29%
% of portfolio
12.31%
Previous 6.95%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023
SELL
$26.2 - $36.08 $1,834 - $2,525
-70 Reduced 0.01%
820,239 $22 Billion
Q2 2023

Jul 26, 2023
SELL
$25.16 - $41.38 $276 - $455
-11 Reduced -0.0%
820,309 $29.3 Billion
Q4 2022

Jan 19, 2023
BUY
$28.0 - $40.56 $23 Million - $33.3 Million
820,320 New
820,320 $33.3 Billion

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $4.37B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Western Financial Corp/Ca Portfolio

Follow Western Financial Corp/Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Financial Corp/Ca, based on Form 13F filings with the SEC.

News

Stay updated on Western Financial Corp/Ca with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email